Press release
Orally Disintegrating Tablet Market Value Can Reach CAGR 11.5% by 2017-2025
According to Persistence Market Research, the global orally disintegrating tablets market is predicted to grow at a significant pace during the assessment period owing to a rising preference for orally disintegrating tablets among patients and physicians alike; coupled with the fact that orally disintegrating tablets minimize the scope for dosage errors and are ideal for administering to patients of all age groups.
These factors are likely to boost revenue growth of the global orally disintegrating tablets market, which is anticipated to rise from an estimated US$ 11.4 Bn in 2017 to about US$ 27 Bn by the end of 2025, witnessing a CAGR of 11.5% in terms of value during the forecast period.
View Full Report @ https://www.persistencemarketresearch.com/market-research/orally-disintegrating-tablet-market.asp
In this report, Persistence Market Research segments the global orally disintegrating tablets market on the basis of drug class, disease indication, distribution channel, and region.
Global Orally Disintegrating Tablets Market, Forecast by Drug Class
In terms of drug class, the global orally disintegrating tablets market is further segmented into Anti-Psychotics, Anti-Epileptics, CNS Stimulants, Anxiolytics, Anti-Parkinsonian Drugs, Anti-Hypertensives, NSAIDS, Anti-Allergy Drugs, Proton Pump Inhibitor, and Others. Anti-Psychotics drug class will be the reigning segment in terms of market revenue share throughout the forecast period, anticipated to hold about 20% revenue share of the global market by 2025 end. With a noteworthy 15.7% CAGR, this segment will retain its supremacy over other drug class segments during the eight year period.
Get Sample Copy of This Report @ https://www.persistencemarketresearch.com/samples/14572
Global Orally Disintegrating Tablets Market, Forecast by Disease Indication
Under this category, the global market is segmented into Central Nervous System (CNS) Diseases, Gastrointestinal (GI) Diseases, Cardiovascular (CVS) Diseases, Allergy, and Others. CNS Diseases segment will hold maximum revenue share in the global market, and Persistence Market Research forecasts indicate a 55% market share for this segment by the end of the forecast period in 2025. The CNS Diseases segment is forecasted to reach a market valuation of about US$ 15 Bn by 2025 end, registering a CAGR of 13.2%. This is slated to be the most dominant segment by disease indication in the global orally disintegrating tablets market.
Global Orally Disintegrating Tablets Market, Forecast by Distribution Channel
Of the various distribution channels of orally disintegrating tablets viz., Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies, Hospital Pharmacies will be the undisputed leader in terms of market share throughout the forecast period, anticipated to account for nearly 49% value share by the end of 2025. A market valuation of about US$ 13 Bn by the end of 2025 with a 13.2% CAGR is likely to be in store for this segment.
Global Orally Disintegrating Tablets Market, Regional Forecast
Persistence Market Research tracks the performance of the global orally disintegrating tablets market across the key geographies of North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is slated to dominate the global market throughout the forecast period, with an estimated 35% market share and a market value of about US$ 9.7 Bn by the end of 2025. This is reflective of a CAGR of 11.7% during the forecast period.
Request For Customization of This Report @ https://www.persistencemarketresearch.com/request-customization/14572
Global Orally Disintegrating Tablets Market, Vendor Ecosystem
The report profiles some of the leading companies operating in the global orally disintegrating tablets market such as Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca, Mylan N.V., Pfizer Inc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Valeant, GlaxoSmithKline plc., Sun Pharmaceutical Industries Ltd., Bayer AG, Eli Lilly and Company, Dr. Reddy’s Laboratories Ltd, Takeda Pharmaceutical Company Limited, Eisai Co., Ltd., Zydus Cadila, NEOS Therapeutics, Inc., Glenmark, and Unichem Laboratories.
Contact us:
305 Broadway, 7th Floor
New York City, NY 10007
United States
Ph.no. +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com
Website: www.persistencemarketresearch.com
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Orally Disintegrating Tablet Market Value Can Reach CAGR 11.5% by 2017-2025 here
News-ID: 1853272 • Views: …
More Releases from Persistence Market Research
Stadium Lighting Market Soars as LED Replaces Metal Halide with Longer Lifespan …
The stadium lighting market is witnessing unprecedented growth, fueled by the global shift from traditional metal halide lights to energy-efficient LED lighting systems. Metal halide lights, which have dominated stadiums for decades, typically last around 6,000 hours and require frequent replacement, leading to high maintenance costs. In contrast, modern LED stadium lights offer superior durability, water resistance, and shockproof features, with lifespans extending up to 100,000 hours. These advancements are…
Global POS Machines Market Outlook: US$ 18 Bn to US$ 49 Bn by 2033
The Point-of-Sale (POS) machines market has been experiencing significant growth over the past decade, driven by rapid technological advancements and the increasing adoption of digital payment solutions. As of 2022, the global POS machines market was valued at US$ 18,221.3 Million, and it is forecasted to reach US$ 49,365.2 Million by 2033. The market is anticipated to grow at a CAGR of 9.6% from 2023 to 2033, highlighting its robust…
How 3D Scanners Are Transforming Design, Manufacturing, and Entertainment
The 3D scanners market is witnessing remarkable growth as industries increasingly adopt advanced digital solutions for product design, quality control, and cultural documentation. A 3D scanner is defined as a device that analyzes real-world objects to collect data on their shape and appearance, enabling the creation of highly accurate digital models. These models are widely used across applications like movie and video game production, industrial design, prosthetics, reverse engineering, prototyping,…
Intermodal Transport Market Poised for Growth at a Robust CAGR Over the Next Dec …
Overview of the Market
The intermodal transport market is witnessing significant growth globally due to increasing demand for efficient, cost-effective, and environmentally sustainable logistics solutions. Intermodal transport, which involves the seamless integration of multiple transportation modes such as rail, road, and sea, ensures faster and safer movement of goods while reducing operational costs. The market's growth is being driven by the rising adoption of advanced technologies, such as automated gate systems…
More Releases for Disintegrating
Fast Disintegrating Tablets Market Future Prediction Report By 2033
The global fast disintegrating tablets market was valued at approximately USD 13.2 billion in 2023 and is projected to reach around USD 29.0 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 8.2% from 2024 to 2033.
The key factor that drives the market growth and rapid adoption of these tablets among the global population includes the improved patient compliance due to these tablets when compared to the conventional…
Market Prowess: Orally Disintegrating Tablets Market and Strategic Navigation
Growth Market Reports, a leading Market research firm, introduces its latest research report on the 𝐎𝐫𝐚𝐥𝐥𝐲 𝐃𝐢𝐬𝐢𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐢𝐧𝐠 𝐓𝐚𝐛𝐥𝐞𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭, offering a detailed guide to understanding various factors crucial for growth progression. This report amalgamates detailed Market overviews based on segmentations, applications, trends, opportunities, mergers and acquisitions, drivers, and restraints. It showcases current and forthcoming technical and financial details of the Orally Disintegrating Tablets Market. Our comprehensive analysis provides a deep…
Computed Tomography to Drive The Orally Disintegrating Tablet Market
The Orally Disintegrating Tablet Market is expected to climb up the ladder of persistence in the next decade. With various healthcare apps on the anvil, there are also mindfulness apps being tabled. They fall in the category of "Wellness apps". With the world wishing for the post-Covid era to function smoothly, these wellness apps are expected to take the healthcare vertical by storm further.
Improvements in drug delivery mechanism offering quicker…
Global Industry Analysis of Disintegrating Agents
Disintegrating agents are chemical agents consisting of a mixture of substances or a single substance that are added to tablets and other encapsulated formulations to facilitate disintegration of the capsule or tablet into smaller remains for better discharge of the drug in the body. This process helps provide better results of the drug on the body. Disintegrating agents primarily find application in the pharmaceutical industry. These agents are used…
Orally Disintegrating Tablets Market Progresses for Huge Profits During - 2027
A research report on "Orally Disintegrating Tablets Market2019 Industry Research Report. This is a key document as far as the clients and industries are concerned to not only understand the competitive market status that exists currently but also what future holds for it in the upcoming period, i.e., between 2018 and 2027. The report has categorized in terms of region, type, key industries, and application.
Global Orally Disintegrating Tablets Market revenue…
Global Orally Disintegrating Tablet Excipient Market Growth 2019-2024
Market Research Report Store offers a latest published report on Orally Disintegrating Tablet Excipient Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Orally Disintegrating Tablet Excipient market will register a 3.7% CAGR in terms of revenue, the global market size will reach US$ 17110 million by 2024, from US$ 14820…
